Museum of American Exceptionalism
← Still Building

Bethesda to Queens · 14 December 2020 · NIH, American industry and the U.S. Army

Distribution Has Begun

The old record for a new vaccine was four years. NIH scientists designed one in days, industry built the doses before the trials ended, and an Army general got them to every state in a week.

Army Capt. Isaiah Horton, a doctor at Walter Reed National Military Medical Center, gets one of the military’s first COVID-19 shots, 14 December 2020.

The moment · About 09:25 EST · 14 December 2020

Long Island Jewish Medical Center, Queens. A day after the first trucks left Michigan, ICU nurse Sandra Lindsay rolls up her sleeve. Dr. Michelle Chester gives the shot on live television. Eleven months after the virus’s genetic code went online, America’s vaccination campaign begins.

I feel like healing is coming.Sandra Lindsay
Army Capt. Isaiah Horton, a doctor at Walter Reed National Military Medical Center, gets one of the military’s first COVID-19 shots, 14 December 2020.. Lisa Ferdinando / U.S. Department of Defense.
63 daysfrom sequence to first human dose
~95%effective in both Phase 3 trials
636sites in the first week of deliveries
2.9Mdoses to every state in week one

In January 2020 a new coronavirus was spreading and no vaccine for it existed. The fastest vaccine ever made, for mumps, had taken four years. America ran every step at once. Government scientists designed the shot, companies built doses before anyone knew they would work, and the Army planned delivery to every state. Eleven months later, the first trucks rolled.

  1. The code arrives

    Chinese scientists post the genetic sequence of the new coronavirus online. At the NIH Vaccine Research Center, Barney Graham’s team has spent years studying coronavirus spikes for a day like this. Within 24 hours, Kizzmekia Corbett’s group writes two stabilizing mutations into the new spike. On 13 January the team and Moderna lock the sequence for the vaccine, mRNA-1273. Within five days of the genome’s release, production begins.

  2. Mapping the spike

    Jason McLellan’s lab at the University of Texas, working with the VRC, publishes the first atomic map of the new virus’s spike, sharp to 3.5 angstroms. The journal Science accepts it seven days after it arrives. Behind it is the 2P design: two prolines, the most rigid amino acid, swapped into a hinge to hold the spike in the shape the immune system must learn. McLellan’s and Graham’s labs found it on MERS in 2017.

  3. First in human

    At Kaiser Permanente Washington Health Research Institute, the first volunteer gets a dose of mRNA-1273. It has been 63 days since the sequence was chosen. Moderna finished the first clinical batch on 7 February and shipped it to the NIH on 24 February. Forty-five healthy adults, ages 18 to 55, will test it. NIAID director Anthony Fauci says the study was launched in record speed.

  4. Operation Warp Speed

    In the Rose Garden, President Donald Trump announces Operation Warp Speed, a partnership of the Department of Health and Human Services and the Department of Defense. The goal is 300 million doses, with the first ready by January 2021. Moncef Slaoui, who led development of five major vaccines at GlaxoSmithKline, is named chief advisor. Gen. Gustave Perna, whose Army Materiel Command runs a global supply chain of more than 190,000 people, is chief operating officer.

    Gen. Gustave Perna, in uniform at right, stands in the Rose Garden as Operation Warp Speed is launched, 15 May 2020.
    Gen. Gustave Perna, in uniform at right, stands in the Rose Garden as Operation Warp Speed is launched, 15 May 2020.. Shealah Craighead / The White House.
  5. Build it before it is proven

    Moderna and the NIH start their Phase 3 trial. It grows to more than 30,000 volunteers at 100 sites across the country. Pfizer and its German partner BioNTech start theirs the same day. Warp Speed buys before the answers are in: $1.95 billion to Pfizer for 100 million doses delivered after authorization, and up to about $1.5 billion to Moderna to make 100 million while its trial is still running.

  6. Ninety-five percent

    An independent safety board reads the first Moderna results. Of 95 volunteers who caught COVID-19, 90 had the placebo and 5 had the vaccine: 94.5 percent effective. All 11 severe cases are in the placebo group. Two days later Pfizer and BioNTech report their final count from more than 43,000 volunteers: 162 cases on placebo, 8 on vaccine, 95 percent. Both companies have been mass-producing doses during the trials.

  7. Distribution has begun

    On 11 December the FDA authorizes the Pfizer-BioNTech vaccine for emergency use in people 16 and older. The next day General Perna briefs the press. Boxes are being packed, with the emphasis on quality control. Shipments will reach 145 sites on Monday, 425 on Tuesday and the last 66 on Wednesday: 636 locations named in advance by the states and territories.

    Gen. Gustave Perna, 12 December 2020Make no mistake, distribution has begun.
  8. The trucks roll

    Early Sunday at Pfizer’s Kalamazoo plant, workers in fluorescent yellow, hard hats and gloves pack vials into freezer cases with dry ice. UPS and FedEx trucks pull out under U.S. Marshals protection, some bound for the airport in Grand Rapids, where the first cargo plane lifts off. In one week Warp Speed delivers 2.9 million doses to every state and territory, through snowstorms and the holiday rush.

  9. Healing is coming

    At Long Island Jewish Medical Center, ICU nurse Sandra Lindsay, the first to raise her hand when volunteers were asked for, rolls up her sleeve. Dr. Michelle Chester gives the shot shortly before 9:30 a.m., live on television. It is the first COVID-19 vaccination in the United States outside a clinical trial. The same day, Walter Reed starts vaccinating its medical staff.

    Sandra Lindsay, after her shotI feel like healing is coming.

The architects

Dr. Barney Graham, deputy director of the NIH Vaccine Research Center.
Deputy Director, NIH Vaccine Research CenterBarney Graham

Kansas-raised physician and Vanderbilt-trained virologist who helped found the Vaccine Research Center in 2000. He spent years learning to lock viral spikes in shape, starting with RSV. When the new virus came, his team designed the vaccine within 48 hours.

Dr. Kizzmekia Corbett, coronavirus team lead at the NIH Vaccine Research Center.Age 34
Coronavirus Team Lead, NIH Vaccine Research CenterKizzmekia Corbett

North Carolina native with a doctorate from UNC Chapel Hill, at the VRC since 2014. She led the coronavirus team that turned the new spike sequence into mRNA-1273 with Moderna and helped drive the preclinical work that cleared it for human trials.

Jason McLellan in his lab at the University of Texas at Austin, December 2020.
Structural Biologist, University of Texas at AustinJason McLellan

Former VRC postdoctoral fellow who maps viral proteins atom by atom. His lab co-discovered the 2P spike in 2017 and published the first atomic map of the new virus’s spike in February 2020. Moderna, Pfizer-BioNTech, Johnson & Johnson and Novavax all use 2P.

Gen. Gustave F. Perna, command portrait as commanding general of U.S. Army Materiel Command, 2016.Age 60
Chief Operating Officer, Operation Warp SpeedGustave Perna

New Jersey native commissioned in 1981 who rose to four stars and command of Army Materiel Command. He ran Warp Speed’s production and distribution and delivered the first 2.9 million doses to every state and territory in one week.

By the numbers

24 hoursfor the VRC to write the stabilizing 2P mutations into the new spike
3.5 Åsharpness of the first atomic map of the spike, published 19 February 2020
45volunteers in the first human trial, in Seattle
30,000+volunteers in Moderna and the NIH’s Phase 3 trial, at 100 U.S. sites
~100,000Americans who had volunteered for vaccine trials by December 2020
$1.95BPfizer contract for 100 million doses, delivered after authorization
$13Bobligated by HHS and Defense for vaccines by the end of 2020
3,700+locations receiving vaccine in the second week of shipments

Watch, listen, see

Films, photographs and first-hand accounts from across the web. Each opens in a new tab.

“They were the true first recipients of the vaccine. They deserve our utmost respect and appreciation. Without them, we could not be here today. They’re true American heroes.”

Gen. Gustave F. Perna, on the vaccine trial volunteers, 12 December 2020

After

On 18 December the FDA authorized Moderna’s vaccine, the one designed at the NIH, for adults 18 and older. It kept in a standard freezer and shipped in 100-dose cartons, small enough for rural clinics. The next week Warp Speed allocated 7.9 million doses of the two vaccines to more than 3,700 locations.

The Government Accountability Office found both vaccines were authorized less than a year after the virus was sequenced, considerably faster than any vaccine before them in the United States. The old record belonged to another American, Maurice Hilleman of Merck, whose mumps vaccine took four years, from 1963 to 1967.

The 2P spike that Graham, McLellan and their colleagues designed is in the Moderna, Pfizer-BioNTech, Johnson & Johnson and Novavax vaccines. By the end of January 2021, companies had released 63.7 million doses. General Perna retired in July 2021 after more than 40 years in uniform.